Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
Level 5 - mechanism / opinion, no new human data
Narrative review presenting mechanistic reasoning without original human data or systematic synthesis.
PubMed 27366724 · doi:10.4103/2230-8210.183480
What was done
This paper provides a narrative conceptual review examining the pathophysiological intersections between microvascular and macrovascular complications in diabetes mellitus, focusing on shared mechanisms such as hyperglycemia, advanced glycation end products, oxidative stress, inflammation, and vasa vasorum neovascularization.
What was found
The abstract reports no empirical data, sample sizes, or quantitative risk estimates. It describes theoretical and pathological models showing that microangiopathic processes, including capillary basement membrane thickening and tissue hypoxia, contribute directly to the development and acceleration of macrovascular disease like atherosclerosis.
Why it matters
Viewing microvascular and macrovascular complications as an interconnected continuum rather than completely separate pathological entities may help unify clinical risk assessment and therapeutic management in type 2 diabetes.
Limits
The paper is a non-systematic narrative review providing no primary clinical trial data, cohort analyses, or quantitative effect sizes. It relies entirely on descriptive mechanistic models rather than measurable patient outcomes.
Cited by
- context Elevated blood glucose levels cause protein glycosylation that occludes microvascular capillary beds and impairs tissue oxygen delivery.